Expert Lung & Respiratory Care in Shanghai
The Department of Pulmonology (Respiratory Medicine) at Fudan University's Zhongshan Hospital is one of China's leading centers for the diagnosis and management of lung and respiratory diseases. With expertise spanning lung cancer, chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary infections, and interventional bronchoscopy, the department provides comprehensive, evidence-based care for patients with conditions ranging from common respiratory illnesses to complex, rare, and treatment-refractory disease.
For international patients seeking specialist respiratory care in Shanghai, China Medical Concierge Shanghai (CMCS) provides seamless end-to-end support — from medical record translation and specialist scheduling to on-site accompaniment and post-consultation follow-up.
About the Department
Zhongshan Hospital's pulmonology department is a national key clinical specialty with a long history of clinical excellence and research innovation. The department operates a comprehensive respiratory unit encompassing inpatient wards, a respiratory intensive care unit (RICU), a pulmonary function laboratory, a sleep medicine center, and one of China's most advanced interventional bronchoscopy programs.
The department's multidisciplinary approach integrates pulmonology, thoracic surgery, oncology, radiology, and pathology to ensure comprehensive, personalized care for every patient. A dedicated lung cancer MDT meets regularly to review complex cases, and a specialized interstitial lung disease (ILD) clinic provides expert management for patients with fibrotic and inflammatory lung conditions.
Faculty members are active contributors to national and international respiratory guidelines, with publications in leading journals including American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, Chest, and Thorax.
Conditions Treated
- Lung Cancer — Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), including early-stage diagnosis, molecular profiling, targeted therapy, and immunotherapy
- Chronic Obstructive Pulmonary Disease (COPD) — Comprehensive management including pulmonary rehabilitation, bronchoscopic lung volume reduction, and exacerbation prevention
- Asthma — Severe and difficult-to-treat asthma, including biologic therapy (dupilumab, mepolizumab, benralizumab)
- Interstitial Lung Disease (ILD) — Idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, connective tissue disease-associated ILD, and sarcoidosis
- Pulmonary Hypertension — Idiopathic and secondary pulmonary arterial hypertension, including targeted vasodilator therapy
- Pulmonary Infections — Community-acquired pneumonia, hospital-acquired pneumonia, tuberculosis, non-tuberculous mycobacteria (NTM), and fungal infections
- Bronchiectasis — Diagnosis, airway clearance, and management of infective exacerbations
- Pleural Disease — Pleural effusion, empyema, pneumothorax, and mesothelioma
- Sleep-Disordered Breathing — Obstructive sleep apnea (OSA) diagnosis and CPAP/BiPAP therapy
- Pulmonary Embolism & Venous Thromboembolism — Acute management and long-term anticoagulation
- Endobronchial Tumors & Airway Stenosis — Bronchoscopic debulking, stenting, and laser therapy
- Occupational & Environmental Lung Disease — Pneumoconiosis, asbestosis, and hypersensitivity pneumonitis
- Respiratory Failure — Non-invasive ventilation (NIV), high-flow nasal oxygen (HFNO), and mechanical ventilation in the RICU
Advanced Bronchoscopy & Interventional Pulmonology
One of the department's most distinctive strengths is its interventional bronchoscopy program, offering a full range of advanced diagnostic and therapeutic bronchoscopic procedures:
Diagnostic Bronchoscopy
- Endobronchial Ultrasound (EBUS) — EBUS-TBNA for mediastinal and hilar lymph node sampling, enabling minimally invasive lung cancer staging without surgery
- Radial EBUS & Fluoroscopy-Guided Biopsy — Peripheral lung lesion biopsy for lesions beyond the reach of standard bronchoscopes
- Electromagnetic Navigation Bronchoscopy (ENB) — GPS-guided navigation to peripheral pulmonary nodules for biopsy
- Cryobiopsy — Transbronchial cryobiopsy for interstitial lung disease diagnosis, providing larger and better-quality tissue samples than conventional forceps biopsy
- Bronchoalveolar Lavage (BAL) — Fluid sampling for infection, ILD, and malignancy diagnosis
Therapeutic Bronchoscopy
- Endobronchial Valve (EBV) Placement — Bronchoscopic lung volume reduction for severe emphysema
- Airway Stenting — Self-expanding metal and silicone stents for malignant and benign airway stenosis
- Laser & Argon Plasma Coagulation (APC) — Endobronchial tumor debulking and hemostasis
- Bronchial Thermoplasty — Bronchoscopic treatment for severe refractory asthma
- Cryotherapy — Endobronchial cryotherapy for tumor debulking and foreign body removal
- Pleuroscopy (Medical Thoracoscopy) — Minimally invasive pleural space examination and biopsy for undiagnosed pleural effusions
Pulmonary Function & Diagnostic Laboratory
- Spirometry & Full Lung Function Testing — Comprehensive assessment of airflow obstruction, restriction, and diffusion capacity
- Bronchoprovocation Testing — Methacholine and exercise challenge for asthma diagnosis
- Cardiopulmonary Exercise Testing (CPET) — Integrated assessment of cardiac and pulmonary exercise capacity
- Polysomnography — Full overnight sleep study for sleep-disordered breathing diagnosis
- High-Resolution CT (HRCT) Correlation — Close integration with radiology for ILD pattern recognition and lung nodule management
Lung Cancer: A Multidisciplinary Approach
Lung cancer management at Zhongshan Hospital exemplifies the department's multidisciplinary philosophy. Every newly diagnosed lung cancer patient is reviewed by a dedicated MDT comprising pulmonologists, thoracic surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists. Molecular profiling — including EGFR, ALK, ROS1, KRAS, MET, and PD-L1 testing — is performed routinely to guide targeted therapy and immunotherapy decisions.
The department has extensive experience with all approved targeted agents for NSCLC, including first, second, and third-generation EGFR inhibitors (osimertinib), ALK inhibitors (alectinib, lorlatinib), and combination immunotherapy regimens. Access to clinical trials provides patients with opportunities to receive investigational therapies not yet widely available.
Why International Patients Choose Zhongshan Pulmonology
- Advanced Interventional Bronchoscopy — One of China's most comprehensive interventional pulmonology programs, including EBUS, ENB, cryobiopsy, and bronchoscopic lung volume reduction
- Lung Cancer Expertise — Full molecular profiling and access to all approved targeted and immunotherapy agents, plus clinical trials
- Specialized ILD Program — Dedicated clinic with expertise in IPF, hypersensitivity pneumonitis, and connective tissue disease-associated ILD
- Multidisciplinary Care — Regular lung cancer MDT and close integration with thoracic surgery, oncology, and radiology
- Comprehensive Diagnostics — Full pulmonary function laboratory, sleep center, and advanced bronchoscopic diagnostic capabilities
- Cost-Effectiveness — World-class respiratory care at significantly lower cost than equivalent treatment in Western countries
The CMCS Patient Journey
- Initial Inquiry — Share your respiratory history, CT scans, pulmonary function tests, bronchoscopy reports, and pathology results with CMCS.
- Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
- Specialist Matching — We identify the most appropriate pulmonologist or interventional bronchoscopist based on your condition.
- Priority Scheduling — We secure a consultation and, where appropriate, a bronchoscopy or procedure slot with minimal waiting time.
- Travel & Logistics — Assistance with visa invitation letters, accommodation near Zhongshan Hospital, and Shanghai airport transfers.
- On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
- Procedure Support — Full coordination of pre-procedure preparation, bronchoscopy, and post-procedure recovery.
- Post-Treatment Follow-Up — Pathology report translation, molecular profiling result interpretation, and remote follow-up coordination after you return home.
Book a Consultation
If you are seeking expert pulmonology care in Shanghai — whether for lung cancer diagnosis and treatment, advanced bronchoscopy, ILD management, or a complex respiratory condition — CMCS can arrange a specialist consultation with Zhongshan Hospital's pulmonology team.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
댓글 0개